Clinicians Channel  
 
Cardiology  |   Gastroenterology  |   Managed Care  |   Nephrology   |   Oncology  |   Ophthalmology

Welcome
 
RECENT WEBCASTS:

View any of our available webcasts or get information on upcoming programs.
To begin, click on the webcast you wish to view.


 
The Art of Individualized  

Profiles in CML: Case-Based Approaches to Managing Resistance and Improving Outcomes

Over the past 10 years, mortality from chronic myeloid leukemia (CML) has decreased from 2400 deaths in 1997 to 490 deaths in 2007. In this CME/CE webcast, Dr. Moshe Talpaz, and the expert faculty in the treatment of CML discuss BCR-ABL inhibitors and weigh available choices among therapeutic options in determining the best therapy for two actual patients.

This activity has reached its termination date and no longer offers continuing education credit.


The Art of Individualized
 

Brainstorming with the Experts Practical Approaches to the Complex World of HCV

This stimulating and thought-provoking webcast features a renowned faculty panel—led by Ira Jacobson, MD—who shape their experience and the latest research data into presentations that clarify the state of the science. Moderating is Ira Flatow, host of Talk of the Nation: Science Friday® on National Public Radio, who practices his notable art of transforming science into discussion. The result: science made useable, complexity made manageable.

This activity has reached its termination date and no longer offers continuing education credit.
 

 

The Art of Individualized

Targeting the Microtubule: A Novel Approach to Treating Metastatic Breast Cancer

In this 1-hour CME/CE webcast, Harold J. Burstein, MD, PhD, and the expert faculty discuss state-of-the-science updates on the role of microtubules in mitosis and tumor proliferation in breast cancer, emerging microtubule-targeting agents, and treatment paradigms for early-stage and resistant/refractory metastatic breast cancer, punctuated by case-based vignettes that apply these learnings to practice. This is Course 18 of The Advanced Certificate Program: Breast Cancer Management.
This activity has reached its termination date and no longer offers continuing education credit.

 

 

The Art of Individualized
 

A Sea Change in MS Treatment — The Potential of Small Molecules

Recent advances in understanding the pathogenesis of multiple sclerosis and its relation to treatment, the importance of early intervention, and the use of novel small-molecule therapies are resulting in expanded treatment options and new hope for patients with this debilitating disease. Please join a panel of neurology experts at A Sea Change in MS Treatment—The Potential of Small Molecules to discuss these exciting new developments and the evolving strategies and controversies in optimizing outcomes for patients with multiple sclerosis.

This activity has reached its termination date and no longer offers continuing education credit.


The Art of Individualized
 

The Art of Individualized Treatment in the Management of Colorectal Cancer

Richard M. Goldberg, MD, and two pre-eminent experts, Jeffrey A. Meyerhardt, MD, MPH, and Alan P. Venook, MD, explore the state of the science in colorectal cancer (CRC). Using the backdrop of a case study, they delve into the underlying mechanisms of oncogenesis, including key signaling pathways leading to tumorigenesis. This on-demand webcast offers you the opportunity to consider individualized treatment options, such as combination targeted-therapy regimens as alternatives to FOLFOX and monotherapy, as well as the importance of diet and lifestyle issues for patients with CRC.

This activity has reached its termination date and no longer offers continuing education credit.
 

 
Unraveling the Complexities of Menopause Management   Unraveling the Complexities of Menopause Management

Multidisciplinary clinical experts, led by co-chairs Richard J. Santen, MD, and Nanette F. Santoro, MD, help unravel the complexities of menopause management in this engaging multifaceted program.

This CME webcast, produced from a live symposium held during The Endocrine Society’s 90th Annual Meeting, is tailored to meet clinicians’ specific educational needs and areas of interest.

This activity has reached its termination date and no longer offers continuing education credit.
 

Unraveling the Complexities of Menopause Management

Translating Clinical Trial Data into the Community Setting: A Case-Based Approach to Metastatic Colorectal Cancer

Over the past few years, results have become available from a wide variety of clinical trials utilizing numerous combination regimens of chemotherapy and targeted biologics in the treatment of colorectal cancer. Recent clinical trials and their relevance to clinical practice are discussed in this overview.
This activity has reached its termination date and no longer offers continuing education credit.

 

 
  An Interactive, Case-Based Approach to Targeted Therapies for GIST On-Demand Webcast

Dr. Richard M. Goldberg moderates a discussion with gastrointestinal stromal tumor (GIST) experts, Charles D. Blanke, MD, and Margaret von Mehren, MD, who present and discuss the case of a 64-year-old woman with metastatic GIST. Through this case, they illustrate how current diagnosis is informed by recent knowledge of the oncogenesis of GIST. They also talk about the implications of new data with regard to selecting and optimizing targeted therapies for first- and second-line treatment in metastatic disease. Emerging concepts such as adjuvant treatment with targeted therapies, use of genotyping to tailor dosing, and prevention and management of resistance to targeted therapies are explored. Throughout, you will be provided with the opportunity to add your own input on appropriate management and compare your answers with those of your colleagues.

This activity has reached its termination date and no longer offers continuing education credit.
 

Hepatitis C: From Scientific Foundations to New Vistas in Treatment

Hepatitis C: From Scientific Foundations to New Vistas in Treatment

The burden of hepatitis C virus (HCV) places new demands on clinicians to keep up with knowledge of the virus and response to infection. This webcast explores what is known about the HCV life cycle, host immune response to HCV, and nonresponse to treatment. Learn how these factors influence response and inform new directions in therapy. Updates on the latest STAT-C agents (eg, protease and polymerase inhibitors) and other novel HCV treatments are also discussed.

This activity has reached its termination date and no longer offers continuing education credit.

 

Practice Management Update: 2007 and Beyond—Changes in AMD Management
  Practice Management Update:
2007 and Beyond—Changes in AMD Management


Get updated information about current and emerging therapies for age-related macular degeneration (AMD), including agents that target vascular endothelial growth factor, and changes in Medicare reimbursement guidelines for 2007 and beyond.

This activity has reached its termination date and no longer offers continuing education credit.


 

From Science to Practice: Managing CINV and Pain in Breast Cancer Patients
 

From Science to Practice:
Managing CINV and Pain in Breast Cancer Patients


Examine the prevalence of chemotherapy-induced nausea and vomiting (CINV) and pain in breast cancer patients, the impact of these events on refusal/delay of treatment, and management with current and novel products, including neuromodulation and cannibinoids.

This activity has reached its termination date and no longer offers continuing education credit.


 

Who Moved My PEG? The Changing Future of Anti-HCV Therapy
Who Moved My PEG?
The Changing Future of Anti-HCV Therapy


Expert faculty explore novel therapies now emerging under the banner of change, including specifically targeted antiviral therapy for HCV (STAT-C).

This activity has reached its termination date and no longer offers continuing education credit.


 

Approaches to Pediatric Skin and Skin Structure Infections
  New Approaches to Pediatric Skin and Skin Structure Infections

Noted experts in dermatology, pediatrics, and microbiology offer their insights on multiple aspects of uncomplicated skin and skin structure infections (uSSSIs) in pediatric patients.

This activity has reached its termination date and no longer offers continuing education credit.


 

Updated Approaches for Treating Hepatitis B
  Updated Approaches for Treating Hepatitis B

A review of the updated HBV treatment guidelines, recent FDA-approved anti-HBV agents, and the newest data regarding use of lamivudine, adefovir, entecavir, peginterferon, and telbivudine.

This activity has reached its termination date and no longer offers continuing education credit.


 

Expert Perspectives on Hepatitis B Virus and the Infected Patient
  Expert Perspectives on Hepatitis B Virus and the Infected Patient

A solid overview of the virus, including its structure and replication, genotypes, and natural history. Then we will talk about how to make optimal use of available screening and diagnostic tools, as well as how to apply recently updated management guidelines to determine which patients are candidates for treatment.

This activity has reached its termination date and no longer offers continuing education credit.


 

What Pharmacists Need to Know About Targeted Therapies
  What Pharmacists Need to Know About Targeted Therapies

Expert faculty provides oncology pharmacists involved in the care of cancer patients with the latest data on the use of targeted therapies in the treatment of solid tumors.

This activity has reached its termination date and no longer offers continuing education credit.


 

 


Copyright © 1997-2016, Projects In Knowledge, Inc. All rights reserved.
PROJECTS IN KNOWLEDGE • Overlook at Great Notch • 150 Clove Road, 10th Floor • Little Falls, New Jersey 07424 (973) 890-8988

For questions or comments regarding this web site please contact: Webmaster
Privacy Policy